Rheonova Medical develops a medical device called Rheomuco dedicated to the pulmonary diseases market. We help healthcare professionals to follow patients affected by a cystic fibrosis or COPD (chronic obstructive pulmonary disease). Rheomuco makes (i) the personalized prognostic of the cystic fibrosis exacerbation phases, to adapt and anticipate treatments; (ii) a better diagnosis and monitoring of COPD, to avoid hospitalization and heavy emergency treatment.